These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 6173518)
1. Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients. Mancia G; Ferrari A; Gregorini L; Parati G; Pomidossi G; Grassi G; Bertinieri G; Zanchetti A J Cardiovasc Pharmacol; 1981; 3(6):1193-202. PubMed ID: 6173518 [TBL] [Abstract][Full Text] [Related]
2. Extended release felodipine in essential hypertension. Variations in blood pressure during whole-day continuous ambulatory recording. Fariello R; Boni E; Corda L; Cantalamessa A; Zaninelli A; Pollavini G; Alicandri C; Muiesan G Am J Hypertens; 1991 Jan; 4(1 Pt 1):27-33. PubMed ID: 2006994 [TBL] [Abstract][Full Text] [Related]
3. Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily. Müller FB; Allsopp LF; Cooper GL; Bolli P; Frei P; Glaus L; Ritz R; Bühler FR Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):207S-212S. PubMed ID: 4005124 [TBL] [Abstract][Full Text] [Related]
4. Clonidine reduces blood pressure and heart rate oscillations in hypertensive patients. Elghozi JL; Laude D; Janvier F J Cardiovasc Pharmacol; 1991 Jun; 17(6):935-40. PubMed ID: 1714018 [TBL] [Abstract][Full Text] [Related]
5. A sliding intravenous dose schedule for clonidine in hypertensive patients. Velasco M; Gallardo E; Plaja J; Guevara J Clin Pharmacol Ther; 1976 Jul; 20(1):31-5. PubMed ID: 776490 [TBL] [Abstract][Full Text] [Related]
6. Clonidine, acebutolol and their interaction in essential hypertension: effects on blood pressure and the control of water and electrolyte balance. Plouin PF; Degoulet P; Fermé I; Cornette M; Ménard J Eur Heart J; 1983 Nov; 4 Suppl G():7-11. PubMed ID: 6363082 [TBL] [Abstract][Full Text] [Related]
7. A clinical study on the prolonged antihypertensive effect of clonidine in a sustained-release capsule formulation. Martens V; Bentsen P; Hochrein H Pharmatherapeutica; 1980; 2(7):456-61. PubMed ID: 7208540 [TBL] [Abstract][Full Text] [Related]
8. Transdermal clonidine therapy in hypertensive patients. Effects on office and ambulatory recorded blood pressure values. Schaller MD; Nussberger J; Waeber B; Porchet M; Brunner HR JAMA; 1985 Jan; 253(2):233-5. PubMed ID: 3965774 [TBL] [Abstract][Full Text] [Related]
9. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension. Lueg MC; Herron J; Zellner S Clin Ther; 1991; 13(4):471-81. PubMed ID: 1933999 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the antihypertensive effect of TTS clonidine by multiple 24-hour automatic blood pressure monitoring. Mancia G; Parati G; Pomidossi G; Malaspina D; Colombo A; Camesasca C; Groppelli A; Casadei R; Zanchetti A J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S187-93. PubMed ID: 2455177 [TBL] [Abstract][Full Text] [Related]
11. Treatment of hypertensive urgencies and emergencies with nitrendipine, nifedipine, and clonidine: effect on blood pressure and heart rate. Späh F; Grosser KD J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S154-6. PubMed ID: 2468862 [TBL] [Abstract][Full Text] [Related]
12. Clonidine and carotid baroreflex in essential hypertension. Mancia G; Ferrari A; Gregorini L; Zanchetti A Hypertension; 1979; 1(4):362-70. PubMed ID: 541039 [TBL] [Abstract][Full Text] [Related]
13. Noninvasive blood pressure monitoring evaluation of verapamil slow-release 240-mg antihypertensive effectiveness. Novo S; Alaimo G; Abrignani MG; Longo B; Muratore G; Strano A J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S38-41. PubMed ID: 2475683 [TBL] [Abstract][Full Text] [Related]
14. Comparison of sustained-release and standard preparations of clonidine in essential hypertension. Fyhrquist F Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):634-6. PubMed ID: 6365808 [TBL] [Abstract][Full Text] [Related]
15. Blood pressure and blood pressure variability following withdrawal of propranolol and clonidine. Neusy AJ; Lowenstein J J Clin Pharmacol; 1989 Jan; 29(1):18-24. PubMed ID: 2708545 [TBL] [Abstract][Full Text] [Related]
16. Oral clonidine for attenuation of haemodynamic response to laryngoscopy and endotracheal intubation in known hypertensive patients. Mujahid-ul-Islam ; Ahmad I; Rafique K; Kamal R; Abbas F J Ayub Med Coll Abbottabad; 2012; 24(3-4):174-6. PubMed ID: 24669646 [TBL] [Abstract][Full Text] [Related]
17. Antihypertensive effect of a new formulation of slow release oxprenolol in essential hypertension. Pomidossi G; Parati G; Malaspina D; Camesasca C; Motolese M; Zanchetti A; Mancia G J Cardiovasc Pharmacol; 1987 Nov; 10(5):593-8. PubMed ID: 2447411 [TBL] [Abstract][Full Text] [Related]
18. Effect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study. Zhang Y; Agnoletti D; Safar ME; Blacher J Hypertension; 2011 Aug; 58(2):155-60. PubMed ID: 21747047 [TBL] [Abstract][Full Text] [Related]
19. [Clonidine transdermal therapeutic system in essential hypertension: effect and tolerance]. Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W Schweiz Med Wochenschr; 1983 Dec; 113(49):1841-5. PubMed ID: 6676936 [TBL] [Abstract][Full Text] [Related]